Asymptomatic infection after BNT162b2 mRNA COVID-19 vaccination in multiple sclerosis patient.
作者信息
Jakimovski Dejan, Weinstock-Guttman Bianca
机构信息
Jacobs Comprehensive MS Treatment and Research Center, Department of Neurology, Jacobs School of Medicine and Biomedical Sciences University at Buffalo, 1010 Main Street, Buffalo, NY, 14202, USA.
Buffalo Neuroimaging Analysis Center, Department of Neurology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, Buffalo, NY, 14203, USA.
出版信息
Acta Neurol Belg. 2022 Apr;122(2):565-566. doi: 10.1007/s13760-021-01799-8. Epub 2021 Sep 16.
Abstract
摘要
相似文献
1
Asymptomatic infection after BNT162b2 mRNA COVID-19 vaccination in multiple sclerosis patient.BNT162b2 mRNA新冠疫苗接种后多发性硬化症患者的无症状感染
Acta Neurol Belg. 2022 Apr;122(2):565-566. doi: 10.1007/s13760-021-01799-8. Epub 2021 Sep 16.
2
Prominent J Waves and Ventricular Fibrillation Caused by Myocarditis and Pericarditis After BNT162b2 mRNA COVID-19 Vaccination.BNT162b2 mRNA新冠疫苗接种后心肌炎和心包炎导致显著J波和心室颤动
Can J Cardiol. 2022 Jun;38(6):844-847. doi: 10.1016/j.cjca.2022.02.005. Epub 2022 Feb 10.
3
Aseptic meningitis after vaccination of the BNT162b2 mRNA COVID-19 vaccine.接种BNT162b2 mRNA新冠疫苗后发生的无菌性脑膜炎。
Neurol Sci. 2021 Nov;42(11):4433-4435. doi: 10.1007/s10072-021-05543-1. Epub 2021 Aug 11.
4
Safety of Inactivated and mRNA COVID-19 Vaccination Among Patients Treated for Hypothyroidism: A Population-Based Cohort Study.甲状腺功能减退症患者接种灭活新冠疫苗和 mRNA 新冠疫苗的安全性：一项基于人群的队列研究。
Thyroid. 2022 May;32(5):505-514. doi: 10.1089/thy.2021.0684. Epub 2022 Apr 7.
5
Immediate reactions after mRNA SARS-CoV-2 vaccination.新型冠状病毒mRNA疫苗接种后的即时反应。
CMAJ. 2021 Dec 6;193(48):E1842. doi: 10.1503/cmaj.211581. Epub 2021 Nov 12.
6
Post BNT162b2 mRNA COVID-19 vaccination Henoch-Schӧnlein Pupura.
Postgrad Med J. 2022 Dec;98(1166):900-901. doi: 10.1136/postgradmedj-2021-141407. Epub 2022 Jan 12.
7
Why two doses of the BNT162b2 mRNA COVID-19 vaccine? A different strategy to speed up the vaccination process: single-dose of the BNT162b2 mRNA COVID-19 and other vaccines.为什么要接种两剂BNT162b2 mRNA新冠疫苗？一种加快疫苗接种进程的不同策略：单剂BNT162b2 mRNA新冠疫苗及其他疫苗。
Panminerva Med. 2022 Mar;64(1):131-132. doi: 10.23736/S0031-0808.21.04286-5. Epub 2021 Jan 22.
8
Prompt onset of Rowell's syndrome following the first BNT162b2 SARS-CoV-2 vaccination.首次接种BNT162b2新冠疫苗后迅速出现罗威尔综合征。
J Eur Acad Dermatol Venereol. 2021 Jul;35(7):e415-e416. doi: 10.1111/jdv.17225. Epub 2021 Apr 19.
9
Myocarditis After BNT162b2 and mRNA-1273 Vaccination.接种 BNT162b2 和 mRNA-1273 后心肌炎。
Circulation. 2021 Aug 10;144(6):506-508. doi: 10.1161/CIRCULATIONAHA.121.055913. Epub 2021 Jun 16.
10
Severe acute interstitial lung disease after BNT162b2 mRNA COVID-19 vaccination in a patient post HLA-haploidentical hematopoietic stem cell transplantation.1例HLA单倍型相合造血干细胞移植术后患者接种BNT162b2 mRNA新冠疫苗后发生严重急性间质性肺病
Bone Marrow Transplant. 2022 May;57(5):840-842. doi: 10.1038/s41409-022-01633-6. Epub 2022 Mar 10.
引用本文的文献
1
COVID-19 Vaccination in Multiple Sclerosis and Inflammatory Diseases: Effects from Disease-Modifying Therapy, Long-Term Seroprevalence and Breakthrough Infections.多发性硬化症和炎症性疾病中的新冠病毒疫苗接种：疾病修正治疗的影响、长期血清阳性率和突破性感染
Vaccines (Basel). 2022 Apr 28;10(5):695. doi: 10.3390/vaccines10050695.
本文引用的文献
1
Effect of SARS-CoV-2 mRNA vaccination in MS patients treated with disease modifying therapies.SARS-CoV-2 mRNA 疫苗接种对接受疾病修正治疗的 MS 患者的影响。
EBioMedicine. 2021 Oct;72:103581. doi: 10.1016/j.ebiom.2021.103581. Epub 2021 Sep 22.
2
Cross-reactive antibodies against human coronaviruses and the animal coronavirome suggest diagnostics for future zoonotic spillovers.针对人类冠状病毒和动物冠状病毒组的交叉反应性抗体表明，这为未来的人畜共患病溢出提供了诊断方法。
Sci Immunol. 2021 Jul 29;6(61). doi: 10.1126/sciimmunol.abe9950.
3
DMTs and Covid-19 severity in MS: a pooled analysis from Italy and France.DMTs 与多发性硬化症中 COVID-19 严重程度：来自意大利和法国的联合分析。
Ann Clin Transl Neurol. 2021 Aug;8(8):1738-1744. doi: 10.1002/acn3.51408. Epub 2021 Jul 7.
4
Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies.接受高效疾病修正治疗的多发性硬化症患者对新冠病毒mRNA疫苗的体液免疫反应
Ther Adv Neurol Disord. 2021 Apr 22;14:17562864211012835. doi: 10.1177/17562864211012835. eCollection 2021.
5
Association Between Vaccination With BNT162b2 and Incidence of Symptomatic and Asymptomatic SARS-CoV-2 Infections Among Health Care Workers.BNT162b2 疫苗接种与医护人员中出现有症状和无症状 SARS-CoV-2 感染的相关性。
JAMA. 2021 Jun 22;325(24):2457-2465. doi: 10.1001/jama.2021.7152.
6
Disease-modifying therapies and SARS-CoV-2 vaccination in multiple sclerosis: an expert consensus.多发性硬化症的疾病修正治疗和 SARS-CoV-2 疫苗接种：专家共识。
J Neurol. 2021 Nov;268(11):3961-3968. doi: 10.1007/s00415-021-10545-2. Epub 2021 Apr 12.
7
Outcomes and Risk Factors Associated With SARS-CoV-2 Infection in a North American Registry of Patients With Multiple Sclerosis.北美多发性硬化症患者SARS-CoV-2感染的相关结局和风险因素
JAMA Neurol. 2021 Jun 1;78(6):699-708. doi: 10.1001/jamaneurol.2021.0688.
8
Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans.未暴露于 SARS-CoV-2 人群中的选择性和交叉反应性 T 细胞表位。
Science. 2020 Oct 2;370(6512):89-94. doi: 10.1126/science.abd3871. Epub 2020 Aug 4.
9
An interactive web-based dashboard to track COVID-19 in real time.一个基于网络的交互式仪表盘，用于实时追踪新冠病毒。
Lancet Infect Dis. 2020 May;20(5):533-534. doi: 10.1016/S1473-3099(20)30120-1. Epub 2020 Feb 19.
10
Infections, Vaccines and Autoimmunity: A Multiple Sclerosis Perspective.感染、疫苗与自身免疫：多发性硬化症视角
Vaccines (Basel). 2020 Jan 28;8(1):50. doi: 10.3390/vaccines8010050.
Zotero 插件